A detailed history of Armis Advisers, LLC transactions in Incyte Corp stock. As of the latest transaction made, Armis Advisers, LLC holds 3,826 shares of INCY stock, worth $334,009. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,826
Holding current value
$334,009
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 15, 2025

BUY
$55.17 - $71.22 $211,080 - $272,487
3,826 New
3,826 $262 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $19.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Armis Advisers, LLC Portfolio

Follow Armis Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armis Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armis Advisers, LLC with notifications on news.